By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LEO Pharma 

Industriparken 55
DK-2750 Ballerup
Copenhagen      Denmark
Phone: 45-4492-3800 Fax: 45-4494-3040



Company News
LEO Pharma Puts Up €675 Million for Astellas (ALPMY)'s Global Dermatology Biz 11/11/2015 6:13:07 AM
LEO Pharma Announces FDA Approval Of Enstilar(Calcipotriene And Betamethasone Dipropionate) Foam, 0.005%/0.064% For Plaque Psoriasis 10/19/2015 7:58:47 AM
LEO Pharma Release: New Study Investigating The Effect Of Low-Molecular-Weight Heparins On The Treatment Of Blood Clots In Cancer Patients 8/19/2015 6:49:48 AM
LEO Pharma Supports The FDA's Selection Of Psoriasis As A Priority Disease 8/4/2015 8:36:39 AM
LEO Pharma Announces New Vice President Of Sales 7/6/2015 7:26:35 AM
LEO Pharma And Professional Football Player Jonathan Scott Partner To Increase Psoriasis Awareness 6/8/2015 2:09:56 PM
arGEN-X, LEO Pharma Forge $116 Million Skin Pact 5/22/2015 5:37:49 AM
Antares Pharma, Inc. (ATRS) Regains U.S. Marketing Rights To OTREXUP For Psoriasis Indication - Announces Termination Of LEO Pharma Marketing Agreement 4/27/2015 7:39:24 AM
Fidelta Achieves Milestone In Collaboration With LEO Pharma 3/3/2015 8:11:05 AM
LEO Pharma Announces New Drug Application Submission of the First Aerosol Foam for Plaque Psoriasis 1/6/2015 7:56:09 AM